Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
1. ISSUES PRESENTED AND CONSIDERED
(i) Whether the imported "embolization coil" is classifiable as an "other artificial part of the body" under tariff item 9021 39 00, or as an "other appliance ... implanted in the body, to compensate for a defect or disability" under tariff item 9021 90 90.
2. ISSUE-WISE DETAILED ANALYSIS
Issue (i): Classification between tariff items 9021 39 00 and 9021 90 90
Legal framework (as discussed by the Court): The Court applied the General Rules for Interpretation, primarily Rule 1 (classification by terms of headings and relative notes) and considered the scope of Heading 9021 and its competing "other" sub-categories, read with the explanatory material reproduced and relied upon in the reasoning to distinguish (a) "artificial parts of the body" that replace defective parts, from (b) other wearable/carried/implantable appliances compensating a defect or disability.
Interpretation and reasoning: The Court found that Heading 9021 covers the product at the four-digit level as an implanted device intended to compensate for a defect. The determinative question was whether it qualifies as an "artificial part of the body" under 9021 39 00. On the facts, the embolization coil is implanted into an existing blood vessel/aneurysmal cavity to induce controlled thrombosis and achieve occlusion; it does not replicate, replace, or substitute the anatomical structure of a vessel or aneurysm wall segment. The Court treated anatomical replacement/substitution as a necessary condition for 9021 39 00, and held that while "resemblance" may not be an absolute test, the requirement of substitution/replacement of anatomy is non-negotiable for classification as an artificial body part. The coil's therapeutic mechanism-deliberate intravascular occlusion while the native vessel continues to exist-fails that replacement test. The Court further reasoned that, by elimination, once 9021 31/39 is inapplicable, the appropriate residual classification is 9021 90 90, which covers implanted appliances compensating a defect or disability but not replacing anatomy.
Conclusions: The Court rejected classification under 9021 39 00 and conclusively held that the embolization coil is classifiable under Heading 9021, specifically tariff item 9021 90 90, as an implanted appliance compensating for a defect/disability without anatomical substitution.